COGT stock

Cogent Biosciences Inc [NASDAQ: COGT] surged by $0.39 during the normal trading session on while it closed the day at $8.95. The company report on February 22, 2024 at 2:30 PM that Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in

Cogent Biosciences Inc [NASDAQ: COGT] gained 59.34% or 3.24 points to close at $8.70 with a heavy trading volume of 10722143 shares. The company report on February 14, 2024 at 7:00 AM that Cogent Biosciences Announces Oversubscribed $225 Million Private Placement. Pro-forma cash, cash equivalents